Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Sweeney

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
The Biochemical Journal|August 6, 2013
TRAF6-mediated ubiquitination of APPL1 enhances hepatic actions of insulin by promoting the membrane translocation of AktKenneth K Y Cheng, Karen S L Lam, Yu Wang, et al.
International Journal of Molecular Sciences|March 11, 2023
Discovery-Based Proteomics Identify Skeletal Muscle Mitochondrial Alterations as an Early Metabolic Defect in a Mouse Model of β-ThalassemiaPatricia Reboucas, Carine Fillebeen, Amy Botta, et al.
American Journal of Translational Research|February 23, 2012
Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodelingBo Yang, Pengcheng Fan, Aimin Xu, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 4, 2013
Distinct metabolic and vascular effects of dietary triglycerides and cholesterol in atherosclerotic and diabetic mouse modelsMarc-André Laplante, Alexandre Charbonneau, Rita Kohen Avramoglu, et al.
Diabetes|January 14, 2010
Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesityIvy K M Law, Aimin Xu, Karen S L Lam, et al.
Journal of Extracellular Vesicles|February 9, 2026
Lipidomic Analysis of Plasma Extracellular Vesicles from Adiponectin Deficient Mice or Metabolic Syndrome Patients Reveals Pro-Oxidative and Pro-Inflammatory Lipid Signatures Correlating with Metabolic DysfunctionSungji Cho, Hye Kyoung Sung, Khang Nguyen, et al.
Clinical Chemistry|October 17, 2006
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humansYu Wang, Karen S L Lam, Edward W Kraegen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 5, 2024
Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF)Sungji Cho, Keith Dadson, Hye Kyoung Sung, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2014
Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitusKhai Le Quang, Rihab Bouchareb, Dominic Lachance, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2018
Holo-lipocalin-2-derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytesErfei Song, Sofhia V Ramos, Xiaojing Huang, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
The Biochemical Journal|August 6, 2013
TRAF6-mediated ubiquitination of APPL1 enhances hepatic actions of insulin by promoting the membrane translocation of AktKenneth K Y Cheng, Karen S L Lam, Yu Wang, et al.
International Journal of Molecular Sciences|March 11, 2023
Discovery-Based Proteomics Identify Skeletal Muscle Mitochondrial Alterations as an Early Metabolic Defect in a Mouse Model of β-ThalassemiaPatricia Reboucas, Carine Fillebeen, Amy Botta, et al.
American Journal of Translational Research|February 23, 2012
Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodelingBo Yang, Pengcheng Fan, Aimin Xu, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 4, 2013
Distinct metabolic and vascular effects of dietary triglycerides and cholesterol in atherosclerotic and diabetic mouse modelsMarc-André Laplante, Alexandre Charbonneau, Rita Kohen Avramoglu, et al.
Diabetes|January 14, 2010
Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesityIvy K M Law, Aimin Xu, Karen S L Lam, et al.
Journal of Extracellular Vesicles|February 9, 2026
Lipidomic Analysis of Plasma Extracellular Vesicles from Adiponectin Deficient Mice or Metabolic Syndrome Patients Reveals Pro-Oxidative and Pro-Inflammatory Lipid Signatures Correlating with Metabolic DysfunctionSungji Cho, Hye Kyoung Sung, Khang Nguyen, et al.
Clinical Chemistry|October 17, 2006
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humansYu Wang, Karen S L Lam, Edward W Kraegen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 5, 2024
Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF)Sungji Cho, Keith Dadson, Hye Kyoung Sung, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2014
Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitusKhai Le Quang, Rihab Bouchareb, Dominic Lachance, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2018
Holo-lipocalin-2-derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytesErfei Song, Sofhia V Ramos, Xiaojing Huang, et al.
Pageof 17